Harvard Management Co invested in Covidien in Q2 - filing
August 13, 2014 at 16:06 PM EDT
BOSTON, Aug 13 (Reuters) - Harvard Management Co, which oversees the Ivy League school's $32.7 billion endowment, took a new position in surgical device maker Covidien Plc during the second quarter before news of a planned takeover helped push the stock price higher, a regulatory filing shows.
